HilleVax (HLVX)
(Delayed Data from NSDQ)
$14.10 USD
-0.18 (-1.26%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $14.14 +0.04 (0.28%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Brokerage Reports
HilleVax, Inc. [HLVX]
Reports for Purchase
Showing records 1 - 4 ( 4 total )
Company: HilleVax, Inc.
Industry: Medical - Biomedical and Genetics
Phase 2B NEST-IN1 Topline Mid-2024 - To Define HIL-214 Path For Infants and Adults; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: HilleVax, Inc.
Industry: Medical - Biomedical and Genetics
HIL-214 Progress - Thoughts on NEST-IN1 Phase 2B Topline Expected Mid-2024; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: HilleVax, Inc.
Industry: Medical - Biomedical and Genetics
HLVX Company Report ; Initiation of Coverage
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: HilleVax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for HLVX 112123
Provider: Stock Traders Daily
Analyst: Research Department
|